Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000276179 encodes "DLG2 antisense RNA 1, conserved region 2", which is a non-coding RNA (miscellaneous RNA) and not a protein-coding gene[3]. This gene does not encode a receptor, enzyme, transporter, or known therapeutic target, and its function, if any, has not been characterized in the scientific literature. As such, it is not considered a target for therapeutic intervention or disease monitoring. This entry is *not* suitable for use as a drug target; it is not misspelled, but refers to a non-coding RNA without evidence of therapeutic relevance[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DLG2 antisense RNA 1, conserved region 2 (DLG2-AS1_2).